Polar Capital Holdings PLC Lantheus Holdings, Inc. Transaction History

Polar Capital Holdings PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$60.27 - $90.75 $181,593 - $273,429	-3,013 Reduced 24.42%	9,327 $648,000
Q2 2023 Dec 13, 2023	SELL	$82.41 - $99.65 $207,261 - $250,619	-2,515 Reduced 16.93%	12,340 $1.04 Million
Q2 2023 Aug 14, 2023	SELL	$82.41 - $99.65 $207,261 - $250,619	-2,515 Reduced 16.93%	12,340 $1.04 Million
Q1 2023 Dec 13, 2023	BUY	$47.76 - $82.86 $264,017 - $458,050	5,528 Added 59.27%	14,855 $1.23 Million
Q4 2022 Feb 14, 2023	SELL	$48.76 - $77.67 $146,280 - $233,010	-3,000 Reduced 16.8%	14,855 $757,000
Q3 2022 Nov 14, 2022	SELL	$61.42 - $86.29 $254,585 - $357,672	-4,145 Reduced 18.84%	17,855 $1.26 Million
Q2 2022 Aug 15, 2022	SELL	$55.54 - $72.65 $180,838 - $236,548	-3,256 Reduced 12.89%	22,000 $1.45 Million
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $492,568 - $1.15 Million	-20,287 Reduced 44.54%	25,256 $1.4 Million
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $586,919 - $792,627	26,039 Added 133.51%	45,543 $1.32 Million
Q2 2021 Aug 16, 2021	BUY	$19.51 - $27.64 $380,523 - $539,090	19,504 New	19,504 $539,000

532

68.9M

679K

414K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.31B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.